Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture.
about
Therapies for the bone in mucopolysaccharidosesScaffold-free microtissues: differences from monolayer cultures and their potential in bone tissue engineeringBone sialoproteinBril: a novel bone-specific modulator of mineralizationSelective drug delivery system to bone: small peptide (Asp)6 conjugation.Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.Antigens of bacteria associated with periodontitis.Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury modelMatrix proteins with high affinity for calcium ions are associated with mineralization within the elastic fibers of pseudoxanthoma elasticum dermisConcepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation.Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation.Molecular modulation of calcium oxalate crystallization.Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide.Selective drug delivery to bone using acidic oligopeptides.Osteoblast physiology in normal and pathological conditions.Clinical usefulness of bone markers in prostate cancer with bone metastasis.Vitamin D Effects on Osteoblastic Differentiation of Mesenchymal Stem Cells from Dental TissuesBiomimetic engineering of nanofibrous gelatin scaffolds with noncollagenous proteins for enhanced bone regeneration.A new method for the preparation of bioactive calcium phosphate films hybridized with 1alpha,25-dihydroxyvitamin D3.Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis.Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.Porous bioactive glass and hydroxyapatite ceramic affect bone cell function in vitro along different time lines.High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia.beta-Glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures.Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures.Biosynthesis of bone sialoprotein by a human osteoclast-like cell line (FLG 29.1).Regulation of bone sialoprotein gene transcription by steroid hormones.Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro.Effects of TGF-β1 on mineralization mediated by rat calvaria-derived osteogenic cells.Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype.Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein.Involvement of osteopontin as a core protein in cholesterol gallstone formation.Involvement of osteopontin as a core protein in craniopharyngioma calcification formation.Bone sialoprotein is localized to the root surface during cementogenesis.Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro.
P2860
Q26852308-04D4638C-790B-42D6-B15E-87A322C0C153Q26998529-78E6EEF2-76CC-4642-B377-6D0D48D57AD6Q28141497-3E3F71C9-81D7-47BE-8ADD-D78BD3DC9368Q28580591-F64260B2-5355-41C8-BA90-AE8E347BC8C2Q30869292-246094C4-A335-4D99-A22E-16DB0CF994BAQ33930155-3654DF47-5BD3-4E09-B1B1-D39DA55E3654Q34216288-F8172851-DD6B-41B2-A9E1-F8756EA930D5Q34960867-CC4570FF-7AD2-48E1-B83F-FF17E88D7D9DQ35319254-3B2F8ABA-369B-42BD-BB5A-14289E0A4363Q35755292-3F3F98A7-7A53-4B38-B36B-4CBD6147DD92Q35774140-C33AF4F4-D94B-4E0B-A8FB-ECB3E034C5F8Q35774199-61CDC7C0-C8A1-4333-B216-300AB2B41A84Q36043951-9ACB34C9-AF22-46D9-B47F-E6FEB0C28FE0Q36578585-5452022A-DE48-43E3-B79A-9D4A325F0DEFQ36643385-9F540AF4-826A-46C9-9B34-26B8C5FB7314Q36677856-7D1E5848-8F3F-4F78-A584-FAB297206A19Q36778774-9AFF7184-C949-4C47-AFF0-CE63A83C1213Q36982989-141E4977-7DAC-483E-A354-4F967EFB471EQ37329087-887E0B44-F601-4656-9A98-1CC79CC04CD8Q37814193-2CD1342E-7E57-4A14-A12F-CB23A8E8DCB8Q38026966-C37F52DA-6A10-4EB8-A5BC-997DC7474DF8Q39106978-A6019EBB-8511-42C3-9413-F5B562B05E72Q39183744-47F25BF2-7DBA-4EB0-A0E7-5A2FDD445389Q39826388-373F3448-1C6E-4481-BF96-C1ACFECCB27BQ40411547-521E04BA-0159-484B-9AB8-3C97829E6E25Q40523346-0B7BCA5F-E7C9-4B09-8C96-6E78C7F5261EQ41097304-853C049C-6BE5-45CA-A92F-46112A5EE183Q41101768-A095F987-517E-4DD2-A07F-098DF5FC34BBQ41103007-33131440-DC07-4BAA-9E20-619762D9B829Q41131777-0E1A49DD-3D6F-496C-89F6-B3182A78AA2AQ41376359-4A318BB3-A3D8-4304-AD78-8DD15EC2AE9FQ41402693-D45648B7-7833-47A5-869A-1AE1A2DDDBF4Q41839864-323FBEBC-1169-4850-9A13-F3DDEAF1710CQ42498112-0D398FF2-7EF8-4F93-BD73-4655850B2F6DQ43545497-10059CC8-0556-4B22-A7A1-1B9397AF5514Q44536963-8C8520E8-D199-481B-BA72-106564443B99Q46123340-533F9B98-AA79-40C0-A0AE-681AA0C0248DQ46274017-94723354-40C7-4685-AD57-4F0204B2EA4EQ46295105-355AB7EB-7F8A-463F-9533-A33679B3F438Q46296895-7FFCEBC8-AC72-4CC1-B1C2-F7B8B93B9B0B
P2860
Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@en
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@nl
type
label
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@en
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@nl
prefLabel
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@en
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@nl
P2093
P2860
P356
P1433
P1476
Biosynthesis of bone proteins ...... at calvarial cells in culture.
@en
P2093
P2860
P304
P356
10.1042/BJ2740513
P407
P478
274 ( Pt 2)
P577
1991-03-01T00:00:00Z